AmberGen and Bruker Collaborate on Spatial Biology Imaging Reagents for MALDI-Immunohistochemistry (MALDI-IHC)
Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and Metabolites WATERTOWN, MA, USA, April 8, 2022 /EINPresswire.com/ — WATERTOWN, Massachusetts, April 08, 2022 – Boston-area life science technology company AmberGen Inc. today announced that it has closed a strategic investment by Bruker Corporation, one of […]